Inferior vena cava syndrome (IVCS) arising from acute thrombosis of the inferior vena cava carries significant morbidity and mortality. Conservative management alone is associated with excess risk, making prompt, structured treatment planning essential.
Acute thrombosis of the inferior vena cava requires early assessment and initiation of treatment. The extent of thrombosis and patient-specific factors inform whether management remains conservative or escalates to additional interventional measures decided by an interdisciplinary team.
Anticoagulation is the foundational intervention and should be initiated promptly. Additional endovascular options may be considered alongside it, depending on the clinical picture.
Complete regimen details — including procedural sequencing, specific options, and long-term management — are available in the full protocol →Although anticoagulation is the mainstay for patients with acute IVC thrombosis [11, 12, 67], there is no evidence-based recommendation how long anticoagulation therapy should be maintained after a successful interventional therapy.
In case of VCI-thrombosis anticoagulation should be initiated and an interdisciplinary team of vascular physicians should decide about additional invasive procedures like thrombaspiration and/or thrombolytic therapy.
Although anticoagulation therapy remains fundamental in the treatment of acute IVC thrombosis additional endovascular options including transcatheter thrombolysis, vacuum assisted or mechanical thrombectomy, or a combination of these techniques are increasingly used as acute IVC thrombosis is associated with an excess mortality and morbidity under conservative treatment.
Again, in IVCS related to thrombosis long-term anticoagulation may be preferred at least in cases without identifiable trigger-mechanisms.
View source ↗